Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Resource Library

Pulmonary Stem Cell Populations: Therapeutic Implications

Kurt Stenmark


Reviews

  Sign in to add a review

0 comments
Leave a Comment

Conference: 2012 Neonatal and Childhood Pulmonary Vascular Disease Conference

Release Date: 06.19.2013

Presentation Type: General Sessions

This session was originally presented at the 5th Annual International Neonatal and Childhood Pulmonary Vascular Disease Conference.

Recorded during the 5th Annual International Neonatal and Childhood Pulmonary Vascular Disease Conference, Dr. Kurt Stenmark presents on the potential contribution of inflammatory and progenitor cells to abnormal vascular remodeling.  He reviews the mechanisms leading to inflammation/progenitor cell recruitment, retention and activation, including epigenetic alterations in control of protein expression, and how these factors may lead to alternative therapeutic strategies in pulmonary hypertension.